Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Rheumatoid arthritis.

Lee DM, Weinblatt ME.

Lancet. 2001 Sep 15;358(9285):903-11. Review.

PMID:
11567728
2.

Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis.

Lyseng-Williamson KA, Foster RH.

Pharmacoeconomics. 2004;22(2):107-32. Review.

PMID:
14731052
3.

Innovative treatment approaches for rheumatoid arthritis. Combination therapy.

Borigini MJ, Paulus HE.

Baillieres Clin Rheumatol. 1995 Nov;9(4):689-710. Review.

PMID:
8591649
4.

Rational use of new and existing disease-modifying agents in rheumatoid arthritis.

Kremer JM.

Ann Intern Med. 2001 Apr 17;134(8):695-706. Review.

PMID:
11304108
5.
6.

[New drugs and treatment strategies for rheumatoid arthritis].

Fantini F.

Recenti Prog Med. 2003 Sep;94(9):361-79. Review. Italian.

PMID:
12942798
7.

Rheumatoid arthritis: an overview of new and emerging therapies.

Doan T, Massarotti E.

J Clin Pharmacol. 2005 Jul;45(7):751-62. Review.

PMID:
15951465
8.

Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?

Cannella AC, O'Dell JR.

Curr Opin Rheumatol. 2003 May;15(3):185-92. Review.

PMID:
12707569
9.

Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis.

Feely MG, O'Dell JR.

Curr Opin Rheumatol. 2010 May;22(3):316-20. doi: 10.1097/BOR.0b013e3283383f87. Review.

PMID:
20190639
10.

Rheumatoid arthritis therapy: advances from bench to bedside.

Choi SI, Brahn E.

Autoimmunity. 2010 Nov;43(7):478-92. doi: 10.3109/08916931003674717. Review.

PMID:
20429843
11.

New understanding and approaches to treatment in rheumatoid arthritis.

Tayar JH, Suarez-Almazor ME.

Br Med Bull. 2010;94:201-14. doi: 10.1093/bmb/ldq007. Review.

PMID:
20200013
12.

Drug treatment for rheumatoid arthritis.

Langenegger T, Michel BA.

Clin Orthop Relat Res. 1999 Sep;(366):22-30. Review.

PMID:
10627714
13.
14.

The importance of early treatment for the prognosis of rheumatoid arthritis.

Kyburz D, Finckh A.

Swiss Med Wkly. 2013 Sep 19;143:w13865. doi: 10.4414/smw.2013.13865. Review.

15.

Rheumatoid arthritis.

Scott DL, Wolfe F, Huizinga TW.

Lancet. 2010 Sep 25;376(9746):1094-108. doi: 10.1016/S0140-6736(10)60826-4. Review.

PMID:
20870100
16.

DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.

Simon LS.

Int J Clin Pract. 2000 May;54(4):243-9. Review.

PMID:
10912314
17.

Therapy of rheumatoid arthritis: new developments and trends.

St Clair EW.

Curr Rheumatol Rep. 1999 Dec;1(2):149-56. Review.

PMID:
11123029
18.

Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.

Singh JA, Cameron DR.

J Manag Care Pharm. 2012 May;18(4 Supp C):S1-18. Review.

PMID:
22656072
19.

Therapeutic options for rheumatoid arthritis.

Feely MG, Erickson A, O'Dell JR.

Expert Opin Pharmacother. 2009 Sep;10(13):2095-106. doi: 10.1517/14656560903071043. Review.

PMID:
19606939
20.

Rheumatoid arthritis and primary care: the case for early diagnosis and treatment.

Calabrese LH.

J Am Osteopath Assoc. 1999 Jun;99(6):313-21. Review.

PMID:
10405518
Items per page

Supplemental Content

Support Center